Molecular Autism

投稿咨询

官方网站：http://molecularautism.biomedcentral.com/

投稿网址：https://www.editorialmanager.com/mola/default.aspx

PMC链接：http://www.ncbi.nlm.nih.gov/nlmcatalog?term=2040-2392%5BISSN%5D

《分子自闭症》是一本经过同行评审的开放获取期刊，出版高质量的基础、转化和临床研究，与自闭症的病因学、病理生物学或治疗以及相关的神经发育条件有关。鼓励包括跨级别集成的研究。分子自闭症发表经验研究、评论和简短的交流。我们鼓励来自不同领域的投稿，包括(但不限于)遗传学、分子神经生物学、神经病理学、神经成像、认知神经科学、流行病学和生物标志物的发现。《分子自闭症》杂志还发表了关于筛查、诊断和分类的文章，包括考虑进行分组以改进我们对基本机制的理解的文章。干预研究也很受欢迎，尤其是在考虑揭示因果机制时。虽然主要关注自闭症谱系障碍(包括阿斯伯格综合症)，但范围包括对相关神经发育障碍的分子研究，如特定语言障碍、运动障碍和特定或一般发育迟缓;和相关的医学症状，如脆性X综合征，结节性硬化症，和勒特综合症。《分子自闭症》也考虑没有分子数据的文章，但从长远来看，这些文章可能会缩小自闭症患者从分子到行为之间的差距。该杂志欢迎来自这一复杂事件链的两端的报告和对优秀科学的评论:要么从分子上，要么从行为上。报告和审查可以是基本的和/或翻译的。请注意，由于我们很少接受未经请求的评审，如果潜在评审的作者认为某个重要主题没有得到充分的评审，并且在理想情况下，他们建议进行系统评审，我们强烈建议他们使用提交前查询系统。

Molecular Autism is a peer-reviewed, open access journal that publishes high-quality basic, translational and clinical research that has relevance to the etiology, pathobiology, or treatment of autism and related neurodevelopmental conditions. Research that includes integration across levels is encouraged. Molecular Autism publishes empirical studies, reviews, and brief communications.We encourage submissions from a range of fields including (but not restricted to) genetics, molecular neurobiology, neuropathology, neuroimaging, cognitive neuroscience, epidemiology, and biomarker discovery. Molecular Autism also publishes articles on screening, diagnosis and classification, including articles that consider subgrouping to refine our understanding of basic mechanisms. Intervention studies are also welcome, especially when considered with respect to revealing causal mechanisms.Although the primary focus is on conditions on the autism spectrum (including Asperger syndrome), the scope encompasses molecular research into related neurodevelopmental conditions such as specific language impairment, dyspraxia, and specific or general developmental delays; and into related medical syndromes such as fragile X syndrome, tuberous sclerosis, and Rett syndrome.Molecular Autism also considers articles with no molecular data but which, in the long-term, may close the gap from molecule to behavior in autism. The journal welcomes reports and reviews of good science that proceed from either end of this complex chain of events: from molecule upwards, or from behavior downwards. Reports and reviews can be basic and/or translational. Note that, because we rarely accept unsolicited reviews, we strongly encourage authors of potential reviews to make use of the presubmission inquiry system if they feel that an important topic has not been adequately reviewed and where, ideally, they are proposing a systematic review.